A commercial agent that returns a confident wrong answer is more dangerous than one that returns nothing.
When a rep asks which cardiologists in a territory perform a given procedure and the agent invents an NPI, pads a volume figure, or lists a physician who stopped doing the procedure two years ago, the error does not stay on the screen. It becomes a call sheet, a territory plan, a forecast presented to leadership. The rep drives to the wrong office.
The market gets sized against demand that was never there.
Every answer an agent gives traces back to what it read to produce that answer. Ask a general model a healthcare question with no connection to live data, and it generates a response from statistical patterns in its training set, which means it fills gaps with plausible fabrication rather than admitting it does not know. Point the same model at current claims records, and the answer reflects what providers actually billed.
For life-science commercial teams, that difference decides whether an agent is an asset or a liability.
Most life-science teams have moved past debating whether to use an agent. The harder question concerns what the agent stands on when it answers.
An agent is a reasoning layer. It interprets a question, decides which data to pull, and presents a result.
On its own it does not know how many interventional cardiologists in a state perform a specific procedure. It reads that from a data source, and the quality of that source governs everything downstream.
Connecting a model to a live source does not add correctness the source lacks. If the underlying records are stale or self-reported, the agent reports stale, self-reported facts with the same fluent confidence it applies to accurate ones.
Commercial teams already sense this risk. In a 2026 enterprise survey by the AI vendor Sinequa, accuracy ranked as the single largest barrier to agent adoption in healthcare and life sciences, named by 48.8% of respondents, ahead of the reliability and security concerns that topped other industries.
The margin for error in this sector is narrow enough that the data underneath an agent gets scrutinized before the agent itself.
A directory records what a provider or a payor says about a physician. A claim records what the physician did, submitted for reimbursement under specific procedure and diagnosis codes. That distinction is the whole argument for claims data as a grounding layer.
Peer-reviewed pharmacology work treats claims as a reliable record of prescription and procedure activity precisely because the record is generated by the act of billing, not by anyone’s description of their own practice.
For a device team, a spine surgeon’s billed procedure mix answers whether that surgeon belongs in the top decile of targets before a single call is placed. Stated specialty cannot answer that. Observed volume can.
There is a second reason observed behavior beats self-report, and it has to do with incentives. A physician filling out a directory profile or a payor updating a network file has no strong reason to keep every field current, and often no reason to be precise about subspecialty.
A billed claim, by contrast, is generated as a byproduct of getting paid, which means the record exists whether or not anyone remembered to maintain it.
Data produced as a side effect of a transaction tends to be more complete and more current than data someone has to volunteer, and an agent grounded on the former is reading a record that maintains itself.
Coverage completeness decides whether a count is representative or biased. The public programs many datasets lean on reach more than one in three Americans through Medicare, Medicaid, and CHIP, which is substantial but still leaves most working-age commercially insured patients out of view.
A dataset built only on Medicare misses prescribing and procedures for those patients under 65, which skews any market estimate toward an older population.
Reading across commercial, Medicare including Medicare Advantage, and Medicaid gives the agent a fuller denominator, so the counts and volumes it returns are not systematically tilted toward whichever payor happened to be in the data.
For a launch team sizing a therapeutic area that spans age groups, that breadth is the difference between a real number and a partial one presented as whole.
An agent with no trusted structured source has two fallbacks, and both fail in predictable ways. It leans on the model’s training data, or it scrapes whatever unverified web and directory content it can reach.
The first fabricates and the second inherits errors baked into self-reported records.
Medical language models tested on clinical tasks hallucinate at rates reported between 15% and 40%, generating statements that read as authoritative while being factually wrong. The failure is not limited to obscure edge cases.
A 2026 analysis of diagnostic model outputs found a leading model omitted guideline-recommended steps more than half the time while still producing fluent, confident text.
Applied to commercial data, the same tendency invents NPIs, assigns procedures to physicians who never performed them, and reports market sizes that were never counted. Nothing in the output signals which figures are real.
The mechanism behind this failure is worth understanding, because it explains why the problem is worst exactly where commercial teams need reliability most.
A model recalls facts it saw often during training. A specific mid-volume regional physician, a precise procedure count, a current affiliation are the kind of long-tail facts that appear rarely or never in training data, so the model has nothing to retrieve and instead generates a token sequence shaped like a plausible answer.
The more specific and current the question, the more likely the response is manufactured. A rep’s real questions are always specific and current, which puts them squarely in the zone where an ungrounded model performs worst.
Directories are the obvious fallback for an agent reaching for provider data, and they are unreliable at the field level.
Secret-shopper audits have found callers were told a physician practiced a different specialty than the directory listed in roughly 30% of cases, and that about 10% of listed providers had left the group or were never there.
Regulators have documented the same pattern, with inaccurate listings feeding care delays and surprise bills. An agent scraping those fields treats a stated specialty as ground truth. The record it repeats was never verified against what the provider actually does.
Even flagged errors persist. A survey of Pennsylvania marketplace directories, conducted months after inaccuracies were first identified, found only about one in eight entries had been fully corrected, with one plan reaching 35% and another under 9%.
Provider data changes continuously as physicians move, change affiliations, and shift what they treat. Data that decays faster than anyone repairs it becomes a steady source of confident error, and an agent has no way to detect that the record it just read went out of date last quarter.
Grounding an agent on claims changes two things at once. It changes whether the answer is correct, and it changes how much a reviewer can trust the answer without re-checking it by hand.
Both matter for teams that have to defend a targeting decision or a forecast.
In a controlled study across medical question-answering benchmarks, adding real-time retrieval and a fact filter to several models reduced hallucinations by as much as 18% and raised accuracy by up to 16.3%.
The mechanism is straightforward. The model stops generating from memory and starts reporting what a query returned.
For a commercial agent, the query returns a provider count or a procedure volume that exists in the data, so the answer is a lookup rather than a guess dressed as a fact.
Claims arrive coded, and the codes are what let an agent reason at the level a commercial question actually requires.
When the agent can filter on the exact CPT or HCPCS code a device maps to, and the ICD-10 or CCSR diagnosis categories describing the treated condition, it works from clinical reality instead of a broad label.
A taxonomy that reads “cardiology” hides whether a physician performs the specific intervention a product supports. The billed code does not hide it. That granularity moves the agent from approximating a target population to identifying it.
Coded claims also carry a time dimension, which is where the context and recommendation value shows up. Because records accumulate over successive periods, an agent can answer how a physician’s volume is trending, not only what it is today.
A surgeon ramping up a procedure looks different from one winding it down, even when their current-quarter counts match, and that trajectory changes who a rep should prioritize. An agent that reads the history can weigh a recommendation toward the providers whose behavior is moving in the direction a launch depends on, which a static snapshot cannot support.
An answer a reviewer can trace is worth more than a faster answer nobody trusts. When an agent shows the filters it applied and pulls its numbers from a named dataset, a reviewer can follow the count back to its basis and confirm it. That auditability addresses the real bottleneck, which is trust rather than capability.
In a 2026 survey of enterprise leaders, only about one in ten agentic use cases reached production in the prior year, held back largely by trust concerns.
Life-science practitioners have gone further, naming the absence of shared verification standards as the single biggest barrier to relying on agents at all. A claims-grounded answer that carries its own provenance is easier to sign off on.
The value of a claims-grounded agent shows up in the questions a commercial team asks every planning cycle. Each of these is a question where a guessed answer costs money and a documented answer saves it.
Ask how many physicians perform a procedure in a given state and what the national volume for it looks like, and a claims-grounded agent returns counts pulled from billed activity rather than a modeled approximation.
A launch team can size an addressable audience and a national opportunity in one pass, with a clear note on exactly which specialty, procedure, and geography were counted. That note keeps the estimate refinable instead of leaving it a black box, because a planner who disagrees with the scope can adjust it and rerun in the same session.
The alternative most teams live with is a market model assembled by hand over weeks, where the assumptions are buried in a spreadsheet nobody wants to reopen. A grounded agent puts the assumptions on the surface, which is where they belong when a forecast has to hold up in front of finance.
A rep asking for the highest-volume orthopedic surgeons within 25 miles of a city who perform a specific procedure gets a shortlist ordered by billed volume.
Specialty alone would return every orthopedic surgeon in the radius, most of them irrelevant to the product. Procedure volume narrows that to the surgeons whose practice justifies a visit.
The rep walks in already knowing the physician performs the relevant work at scale, which is the difference between a warm conversation and a cold one.
For medical affairs and key opinion leader teams, claims activity sits alongside publications and clinical trial involvement, so an agent can surface providers who both treat the relevant population and shape the literature around it.
A physician who bills high volume in a therapeutic area and leads trials in it is a different kind of target than one who only publishes. Real-world evidence drawn from claims strengthens those engagements because it reflects day-to-day practice, not reputation carried over from a decade ago.
The practical payoff is a shorter, better-justified target list. Instead of a roster of well-known names assembled from conference memory, a medical affairs team gets providers ranked by a combination of current clinical activity and published influence, each of which the agent can point to a source for.
When a field medical lead has to explain why a particular physician made the list, the answer traces to billed volume and citation activity rather than to who happened to be recommended in a hallway conversation.
Alpha Sophia is the leading US healthcare commercial intelligence platform, now agent-native, built on a national view of all-payor US medical claims across 4 million providers. Its role in an agent workflow is specific and worth stating plainly, because the topic invites confusion about what the platform does and does not do.
Alpha Sophia does not replace your agent or your CRM. It supplies the claims-grounded reference the agent looks up. When a question comes in, the system maps plain-language terms like a specialty or a procedure to entries in the database, then returns real providers, NPIs, procedure volumes, and market sizes rather than a model’s approximation.
The healthcare claims data behind it spans commercial, Medicare including Medicare Advantage, and Medicaid, layered with procedures in CPT and HCPCS codes, diagnoses in ICD-10 and CCSR categories, specialty and taxonomy, affiliations and sites of care, prescriptions, open payments, and education, publications, and clinical trials.
The agent reasons and the data stays the thing it reasons over.
Teams reach the same data three ways, and the right one depends on how a team already operates. The in-app Alpha Sophia Assistant turns plain-English questions into filtered provider and site-of-care lists inside the platform, showing the filters it applied so the result can be checked.
Teams that already work in Claude, ChatGPT, or Cursor can connect those tools to Alpha Sophia over the Model Context Protocol and ask their healthcare questions without leaving them.
And fully autonomous workflows can run a sequence end to end, sizing a market, building a target list, and handing the output to a connected CRM or email tool. The data foundation is identical across all three, so the answer does not change with the access path.
So, a team asks for biologic-prescribing rheumatologists in a region, drafted intros for each, queued in the CRM. In a fully autonomous run, the agent finds the qualifying rheumatologists in the claims-grounded data, then carries the result into the connected CRM and email tools, so the sequence completes without anyone opening the platform.
The provider list, the prescribing signal, and the counts all come from the same governed source the in-app assistant would use, which means the automation does not trade accuracy for the convenience of running unattended.
Alpha Sophia supplies the external reference but does not merge records inside your CRM, run deduplication against a golden record, or resolve identities within your systems. That logic stays where it belongs, in your own tooling, with Alpha Sophia serving as the claims-grounded source those systems match toward.
For example:
A market access team pulling a claims-based prevalence estimate for a payer negotiation still runs that number through their own pricing model and contract terms in their internal financial systems. Alpha Sophia supplies the denominator but the deal logic lives elsewhere.
A field medical team surfacing high-volume, high-publication physicians for KOL mapping still resolves those names against an existing CRM record, checks for prior MSL contact history, and applies internal engagement tiering, all inside the CRM. Alpha Sophia hands over the ranked list, while the CRM decides who gets called first and by whom.
In each case, the agentic layer reads from the claims data and your stack decides what to do with the result, which keeps the boundary clean between the reference data and the workflow that consumes it.
For teams planning agentic HCP engagement grounded in claims, that separation keeps the data trustworthy while the automation lives in the systems built to handle it .
An agent will answer either way. Whether that answer reflects billed reality or a model’s best guess depends entirely on what the agent read to produce it.
Claims data is the record of what providers actually did, current and specific enough to rank a target list, size a market, and survive a reviewer’s scrutiny. Ground an agent on that record and its output becomes something a rep can act on and a leader can defend.
The alternative is an agent that keeps answering with the same fluency whether or not it has a basis for the answer, and errors that stay invisible until the territory has already been worked the wrong way.
What is claims-based healthcare data?
Claims-based healthcare data is the administrative record generated each time a covered service is delivered or a prescription is filled. Each record captures the procedure or drug, the diagnosis, the provider, and the setting, coded in standard formats like CPT, HCPCS, and ICD-10.
Why do healthcare AI agents rely on claims data?
An agent generates answers from whatever it can read, and without a trusted source it fills gaps with plausible fabrication. Claims data gives the agent a factual record of billed activity to look up, so counts, volumes, and provider lists reflect reality instead of a model’s guess.
How does claims data improve commercial decision-making?
Claims data replaces assumptions about who treats a condition with evidence of who actually bills for the relevant procedures and diagnoses. Teams can size markets against real volume, rank targets by observed activity, and track how prescribing and procedure patterns shift over time.
What information is included in healthcare claims data?
A claim typically records the provider and their identifiers, the procedure performed as a CPT or HCPCS code, the associated diagnosis as an ICD-10 code, the site of care, and the payor. Enriched with affiliations, prescriptions, open payments, and publication or trial activity, it supports both targeting and market analysis.
Why is data quality important for AI agents?
An agent inherits the accuracy of the data it reads, so grounding it on stale or self-reported records produces fluent answers that happen to be wrong. Provider directories, for instance, frequently list outdated specialties and locations that an ungrounded agent would repeat as fact.
How does Alpha Sophia use claims-based healthcare data for AI agents?
Alpha Sophia is an agent-native commercial intelligence platform built on all-payor US medical claims across 4 million providers. It supplies the claims-grounded reference an agent reads, returning real providers, NPIs, and volumes rather than generated approximations, through an in-app assistant, a connection to tools like Claude or ChatGPT over MCP, or autonomous workflows.